SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-281210
Filing Date
2015-08-06
Accepted
2015-08-06 17:02:24
Documents
11
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d944025d10q.htm 10-Q 506159
2 EX-31.1 d944025dex311.htm EX-31.1 8726
3 EX-31.2 d944025dex312.htm EX-31.2 8732
4 EX-32.1 d944025dex321.htm EX-32.1 3549
5 EX-32.2 d944025dex322.htm EX-32.2 3560
  Complete submission text file 0001193125-15-281210.txt   3346529

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT kerx-20150630.xml EX-101.INS 484182
7 XBRL TAXONOMY EXTENSION SCHEMA kerx-20150630.xsd EX-101.SCH 35630
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kerx-20150630_cal.xml EX-101.CAL 49673
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kerx-20150630_def.xml EX-101.DEF 248558
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE kerx-20150630_lab.xml EX-101.LAB 360829
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kerx-20150630_pre.xml EX-101.PRE 291881
Mailing Address
Business Address 750 LEXINGTON AVENUE . NEW YORK NY 10022 212-531-5965
KERYX BIOPHARMACEUTICALS INC (Filer) CIK: 0001114220 (see all company filings)

IRS No.: 134087132 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30929 | Film No.: 151033978
SIC: 2834 Pharmaceutical Preparations